Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer's disease.
PURPOSE
We aimed to investigate associations between tau pathology and relative cerebral blood flow (rCBF), and their relationship with cognition in Alzheimer's disease (AD), by using a single dynamic [18F]flortaucipir positron emission tomography (PET) scan.


METHODS
Seventy-one subjects with AD (66 ± 8 years, mini-mental state examination (MMSE) 23 ± 4) underwent a dynamic 130-min [18F]flortaucipir PET scan. Cognitive assessment consisted of composite scores of four cognitive domains. For tau pathology and rCBF, receptor parametric mapping (cerebellar gray matter reference region) was used to create uncorrected and partial volume-corrected parametric images of non-displaceable binding potential (BPND) and R1, respectively. (Voxel-wise) linear regressions were used to investigate associations between BPND and/or R1 and cognition. RESULTS: Higher [18F]flortaucipir BPND was associated with lower R1 in the lateral temporal, parietal and occipital regions. Higher medial temporal BPND was associated with worse memory, and higher lateral temporal BPND with worse executive functioning and language. Higher parietal BPND was associated with worse executive functioning, language and attention, and higher occipital BPND with lower cognitive scores across all domains. Higher frontal BPND was associated with worse executive function and attention. For [18F]flortaucipir R1, lower values in the lateral temporal and parietal ROIs were associated with worse executive functioning, language and attention, and lower occipital R1 with lower language and attention scores. When [18F]flortaucipir BPND and R1 were modelled simultaneously, associations between lower R1 in the lateral temporal ROI  and worse attention remained, as well as for lower parietal R1 and worse executive functioning and attention.


CONCLUSION
Tau pathology was associated with locally reduced rCBF. Tau pathology and low rCBF were both independently associated with worse cognitive performance. For tau pathology, these associations spanned widespread neocortex, while for rCBF, independent associations were restricted to lateral temporal and parietal regions and the executive functioning and attention domains. These findings indicate that each biomarker may independently contribute to cognitive impairment in AD.
['Visser|Denise|D|0000-0002-3642-146X', 'Wolters|Emma E|EE|', 'Verfaillie|Sander C J|SCJ|', 'Coomans|Emma M|EM|', 'Timmers|Tessa|T|', 'Tuncel|Hayel|H|', 'Reimand|Juhan|J|', 'Boellaard|Ronald|R|', 'Windhorst|Albert D|AD|', 'Scheltens|Philip|P|', 'van der Flier|Wiesje M|WM|', 'Ossenkoppele|Rik|R|', 'van Berckel|Bart N M|BNM|']
D000544:Alzheimer Disease D002560:Cerebrovascular Circulation D003071:Cognition D060825:Cognitive Dysfunction D006801:Humans D049268:Positron-Emission Tomography D016875:tau Proteins
Tau Relative cerebral blood flow Cognition [18F]flortaucipir PET Alzheimer’s disease